Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Brain Functional Sectors(pBFS) Guided 20min Inter-session Interval rTMS Treatment for Major Depressive Disorder: a Randomized, Double-Blind, Sham-controlled Trial

NCT05957341 is registered in ClinicalTrials.gov with Changping Laboratory as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05957341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Brain Functional Sectors(pBFS) Guided 20min Inter-session Interval rTMS Treatment for Major Depressive Disorder: a Randomized, Double-Blind, Sham-controlled Trial
Lead sponsor
Changping Laboratory
Phase
Not applicable
Overall status
Unknown status
Start date
July 30, 2023
Completion date
August 30, 2024
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, moderate depression, severe depression